Anlai Zou
Papers
1
Total Citations
22
H-Index
1
About
Anlai Zou is a rising leader in biomedical engineering, whose research converges on the frontier of micro/nanorobotics, inflammatory bowel disease (IBD) therapy, and the gut microbiome. Zou’s most cited work introduces a groundbreaking “Microalgae‐Probiotic‐Nanozyme Robot,” a biohybrid system designed to alleviate intestinal inflammation and correct microbiota dysbiosis. This innovative platform ingeniously combines living microalgae, probiotics, and nanozymes to simultaneously combat oxidative stress, restore gut barrier function, and rebalance microbial communities—addressing key limitations of conventional IBD treatments. Garnering 22 citations since its 2025 publication, this work exemplifies Zou’s ability to integrate synthetic biology, nanotechnology, and robotics for targeted therapeutic delivery. By engineering autonomous, bio-inspired robots that navigate the gastrointestinal tract, Zou is pioneering next-generation strategies for chronic inflammatory conditions. Their research not only offers a paradigm shift in treating IBD but also opens new avenues for intelligent, living therapeutics. For students and researchers, Anlai Zou represents the vanguard of interdisciplinary science—where microalgae, probiotics, and nanozymes unite to create smarter, more effective solutions for complex diseases.
Research Focus
Key Achievements
Top Papers
- 1